April 14, 2012

Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

Several studies have shown significant rates of ventricular tachyarrhythmia events while on VAD support, ranging from 22% -52%.  This single center study noted the mean time to first shock after LVAD implant was 129 ± 109 days, the LVAD cohort was more likely to have an appropriate ICD before LVAD implant than after and a survival benefit occurred in patients who received an ICD.

Cardiac Transplantation

Tags: , , ,